Fujifilm Healthcare Americas has received U.S. Food and Drug Administration (FDA) clearance for its new compact, 128-slice CT system, FCT iStream.
Fujifilm's new FCT iStream CT scanner. Image courtesy of Fujifilm.
The system features four core proprietary Fujifilm technologies, including HiMAR Plus (High image quality Metal Artifact Reduction), Intelli IPV, SynergyDrive, and IntelliODM; these technologies enhance the sharpness of images, streamline workflow through AI automation, and significantly reduce patient dose, the company said.
To streamline technologist workflow, the system captures 60 images per second and uses Fujifilm’s SynergyDrive technology to automate, simplify, and accelerate the scanning process. SynergyDrive helps streamline the entire image capture process, assisting with automating the positioning of the patient inside the CT system, mapping imaging parameters on where to scan, and scanning and archiving the images, Fujifilm added.
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
